Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice

Nature Communications

Volumn 6, Issue , 2015, Pages

  Huang, Yen Lin ^a   Chassard, Christophe ^b,e   Hausmann, Martin ^c   Von Itzstein, Mark ^d   Hennet, Thierry ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d GRIFFITH UNIVERSITY   (Australia)

^e Institut National de la Recherche Agronomique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; METRONIDAZOLE; NEOMYCIN; PENICILLIN DERIVATIVE; SIALIC ACID; SIALIDASE INHIBITOR; STREPTOMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; DEXTRAN SULFATE; N ACETYLNEURAMINIC ACID; SIALIDASE;

BACTERIOLOGY; CATABOLISM; CHRONOLOGY; ENZYME ACTIVITY; GASTROENTERITIS; MICROBIAL ACTIVITY; MONOSACCHARIDE; ORAL HEALTH; PROTEIN; RODENT; SALT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTEROIDACEAE; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES VULGATUS; CATABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DYSBIOSIS; ENTERITIS; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLORA; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PARABACTEROIDES DISTASONIS; PORPHYROMONADACEAE; RUMINOCOCCACEAE; SHORT COURSE THERAPY; ANIMAL; BACTEROIDES; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; ENZYMOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

BACTEROIDES VULGATUS; ESCHERICHIA COLI; MUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTEROIDES; COLITIS; DENDRITIC CELLS; DEXTRAN SULFATE; ESCHERICHIA COLI; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIOTA; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE;

EID: 84940062118     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9141     Document Type: Article

References (56)

1. Wang, Y. et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 3, 944-954 (2009).
2. Kamada, N., Seo, S. U., Chen, G. Y., Nunez, G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321-335 (2013).
3. Zhao, L. The gut microbiota and obesity: from correlation to causality. Nat. Rev. Microbiol. 11, 639-647 (2013).
4. Oertli, M. et al. Helicobacter pylori gamma-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance. Proc. Natl Acad. Sci. USA 110, 3047-3052 (2013).
5. Scher, J. U., Abramson, S. B. The microbiome and rheumatoid arthritis. Nat. Rev. Rheumatol. 7, 569-578 (2011).
6. Louis, P., Hold, G. L., Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661-672 (2014).
7. El Kaoutari, A., Armougom, F., Gordon, J. I., Raoult, D., Henrissat, B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 11, 497-504 (2013).
8. Chassard, C., Lacroix, C. Carbohydrates and the human gut microbiota. Curr. Opin. Clin. Nutr. Metab. Care. 16, 453-460 (2013).
9. Zivkovic, A. M., German, J. B., Lebrxcilla, C. B., Mills, D. A. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc. Natl Acad. Sci. USA 108, 4653-4658 (2011).
10. Marcobal, A. et al. Consumption of human milk oligosaccharides by gut-related microbes. J. Agric. Food. Chem. 58, 5334-5340 (2010).
11. Pacheco, A. R. et al. Fucose sensing regulates bacterial intestinal colonization. Nature 492, 113-117 (2012).
12. Bouchet, V. et al. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc. Natl Acad. Sci. USA 100, 8898-8903 (2003).
13. Harvey, H. A., Swords, W. E., Apicella, M. A. The mimicry of human glycolipids and glycosphingolipids by the lipooligosaccharides of pathogenic neisseria and haemophilus. J. Autoimmun. 16, 257-262 (2001).
14. Carlin, A. F., Lewis, A. L., Varki, A., Nizet, V. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J. Bacteriol. 189, 1231-1237 (2007).
15. Aspholm, M. et al. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog. 2, e110, doi:10.1371/journal.ppat.0020110 (2006).
16. Byres, E. et al. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 456, 648-652 (2008).
17. Kashyap, P. C. et al. Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota. Proc. Natl Acad. Sci. USA 110, 17059-17064 (2013).
18. Fuhrer, A. et al. Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J. Exp. Med. 207, 2843-2854 (2010).
19. Kurakevich, E., Hennet, T., Hausmann, M., Rogler, G., Borsig, L. Milk oligosaccharide sialyl(alpha2,3)lactose activates intestinal CD11c\+ cells through TLR4. Proc. Natl Acad Sci USA 110, 17444-17449 (2013).
20. Lupp, C. et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 204 (2007).
21. Schuppler, M., Lotzsch, K., Waidmann, M., Autenrieth, I. B. An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice. Infect. Immun. 72, 1983-1990 (2004).
22. Maheux, A. F. et al. Analytical comparison of nine PCR primer sets designed to detect the presence of Escherichia coli/Shigella in water samples. Water Res. 43, 3019-3028 (2009).
23. Chen, J., Griffiths, M. W. PCR differentiation of Escherichia coli from other gram-negative bacteria using primers derived from the nucleotide sequences flanking the gene encoding the universal stress protein. Lett. Appl. Microbiol. 27, 369-371 (1998).
24. Fukushima, M., Kakinuma, K., Kawaguchi, R. Phylogenetic analysis of Salmonella, Shigella, and Escherichia coli strains on the basis of the gyrB gene sequence. J. Clin. Microbiol. 40, 2779-2785 (2002).
25. Kim, S., Oh, D. B., Kang, H. A., Kwon, O. Features and applications of bacterial sialidases. Appl. Microbiol. Biotechnol. 91, 1-15 (2011).
26. Varki, A., Gagneux, P. Multifarious roles of sialic acids in immunity. Ann. NY Acad. Sci. 1253, 16-36 (2012).
27. Roy, S., Douglas, C. W., Stafford, G. P. A novel sialic acid utilization and uptake system in the periodontal pathogen Tannerella forsythia. J. Bacteriol. 192, 2285-2293 (2010).
28. Nagalingam, N. A., Lynch, S. V. Role of the microbiota in inflammatory bowel diseases. Inflamm. Bowel. Dis. 18, 968-984 (2012).
29. Winter, S. E. et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708-711 (2013).
30. Singh, V. et al. Interplay between enterobactin, myeloperoxidase and lipocalin 2 regulates E. coli survival in the inflamed gut. Nat. Commun. 6, 7113 (2015).
31. Chang, D. E. et al. Carbon nutrition of Escherichia coli in the mouse intestine. Proc. Natl Acad. Sci. USA 101, 7427-7432 (2004).
32. Fabich, A. J. et al. Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect. Immun. 76, 1143-1152 (2008).
33. Gophna, U., Sommerfeld, K., Gophna, S., Doolittle, W. F., Veldhuyzen van Zanten, S. J. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 44, 4136-4141 (2006).
34. Ng, K. M. et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96-99 (2013).
35. Parker, N., Tsai, H. H., Ryder, S. D., Raouf, A. H., Rhodes, J. M. Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion 56, 52-56 (1995).
36. Campbell, B. J., Yu, L. G., Rhodes, J. M. Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconj. J. 18, 851-858 (2001).
37. Delahooke, D. M., Barclay, G. R., Poxton, I. R. A re-appraisal of the biological activity of bacteroides LPS. J. Med. Microbiol. 42, 102-112 (1995).
38. Takada, H. et al. Bacteroides lipopolysaccharides (LPS) induce anaphylactoid and lethal reactions in LPS-responsive and-nonresponsive mice primed with muramyl dipeptide. J. Infect. Dis. 162, 428-434 (1990).
39. Poxton, I. R., Edmond, D. M. Biological activity of Bacteroides lipopolysaccharide-reappraisal. Clin. Infect. Dis. 20, S149-S153 (1995).
40. Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009).
41. Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689 (2009).
42. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
43. Mazmanian, S. K., Round, J. L., Kasper, D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625 (2008).
44. Bernhard, A. E., Field, K. G. Identification of nonpoint sources of fecal pollution in coastal waters by using host-specific 16S ribosomal DNA genetic markers from fecal anaerobes. Appl. Environ. Microbiol. 66, 1587-1594 (2000).
45. Fierer, N., Jackson, J. A., Vilgalys, R., Jackson, R. B. Assessment of soil microbial community structure by use of taxon-specific quantitative PCR assays. Appl. Environ. Microbiol. 71, 4117-4120 (2005).
46. Schmittgen, T. D., Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108 (2008).
47. Andersson, A. F. et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE 3, e2836 (2008).
48. De Filippo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. USA 107, 14691-14696 (2010).
49. Ellies, L. G. et al. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc. Natl Acad. Sci. USA 99, 10042-10047 (2002).
50. Napolitano, L. M., Koruda, M. J., Meyer, A. A., Baker, C. C. The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock 5, 202-207 (1996).
51. Duncan, S. H., Hold, G. L., Harmsen, H. J., Stewart, C. S., Flint, H. J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 52, 2141-2146 (2002).
52. Sambrook, J., Russell, D. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, 2001).
53. Thompson, H., Homer, K. A., Rao, S., Booth, V., Hosie, A. H. F. An orthologue of Bacteroides fragilis NanH is the principal sialidase in Tannerella forsythia. J. Bacteriol. 191, 3623-3628 (2009).
54. Hara, S. et al. Determination of mono-O-acetylated N-acetylneuraminic acids in human and rat sera by fluorometric high-performance liquid chromatography. Anal. Biochem. 179, 162-166 (1989).
55. von Itzstein, M., Wu, W. Y., Jin, B. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. Carbohydr. Res. 259, 301-305 (1994).
56. Hausmann, M. et al. In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis. Clin. Exp. Immunol. 148, 373-381 (2007).